Form 4 for AURA Aura Biosciences, Inc.
Accepted 2025-06-04 00:00:00 ET · period of report 2025-06-02 · accession 0000950170-25-081615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-04 | 2025-06-02 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $5.07 | +10.9K | 493.4K | +2% | +$55.5K |
| D | 2025-06-04 | 2025-06-02 | AURA | de los Pinos Elisabet | See Remarks, Dir | F - Tax | $6.16 | -9,948 | 483.4K | -2% | -$61.3K |
| D | 2025-06-04 | 2025-06-02 | AURA | de los Pinos Elisabet | See Remarks, Dir | M - OptEx | $0.00 | -10.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-02 | M | A | 10,948 | $5.07 | 493,388 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-02 | F | D | 9,948 | $6.16 | 483,440 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-06-02 | M | D | 10,948 | $0.00 | 0 | D | $5.07 · — to 2025-06-02 | 10,948 Common Stock | (F3) This option is fully vested. |